These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 12401165)

  • 21. Premenstrual syndrome in adolescents: diagnosis and treatment.
    Rapkin AJ; Mikacich JA
    Pediatr Endocrinol Rev; 2006 Jan; 3 Suppl 1():132-7. PubMed ID: 16641847
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Premenstrual syndrome (PMS)].
    Hamatani T; Mizusawa Y; Kuji N; Yoshimura Y
    Nihon Rinsho; 2006 Jun; Suppl 2():389-94. PubMed ID: 16817427
    [No Abstract]   [Full Text] [Related]  

  • 23. [The premenstrual syndrome].
    van der Leij F; Schultz WC; van de Wiel H; van Leeuwen JH
    Ned Tijdschr Geneeskd; 2010; 154():A1341. PubMed ID: 20719012
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Management strategies for premenstrual syndrome/premenstrual dysphoric disorder.
    Jarvis CI; Lynch AM; Morin AK
    Ann Pharmacother; 2008 Jul; 42(7):967-78. PubMed ID: 18559957
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Integrative treatments for premenstrual syndrome.
    Low Dog T
    Altern Ther Health Med; 2001; 7(5):32-9; quiz 40, 139. PubMed ID: 11565400
    [No Abstract]   [Full Text] [Related]  

  • 26. Selective serotonin reuptake inhibitors for premenstrual syndrome and premenstrual dysphoric disorder: a meta-analysis.
    Shah NR; Jones JB; Aperi J; Shemtov R; Karne A; Borenstein J
    Obstet Gynecol; 2008 May; 111(5):1175-82. PubMed ID: 18448752
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is it premenstrual syndrome? Keys to focused diagnosis, therapies for multiple symptoms.
    Frye GM; Silverman SD
    Postgrad Med; 2000 May; 107(5):151-4, 157-9. PubMed ID: 10844948
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Medical management of premenstrual dysphoric disorder.
    Yonkers KA
    J Gend Specif Med; 1999; 2(3):55-60. PubMed ID: 11252853
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Double-blind, placebo-controlled pilot study of adjunctive quetiapine SR in the treatment of PMS/PMDD.
    Jackson C; Pearson B; Girdler S; Johnson J; Hamer RM; Killenberg S; Meltzer-Brody S
    Hum Psychopharmacol; 2015 Nov; 30(6):425-34. PubMed ID: 26193781
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical practice. Premenstrual dysphoric disorder.
    Grady-Weliky TA
    N Engl J Med; 2003 Jan; 348(5):433-8. PubMed ID: 12556546
    [No Abstract]   [Full Text] [Related]  

  • 31. Alprazolam and premenstrual syndrome.
    Freinhar JP
    J Clin Psychiatry; 1984 Dec; 45(12):526. PubMed ID: 6150031
    [No Abstract]   [Full Text] [Related]  

  • 32. [PMS and PMDD].
    Leminen H; Paavonen J
    Duodecim; 2013; 129(17):1756-63. PubMed ID: 24159708
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Premenstrual syndrome therapy.
    Johnson SR
    Clin Obstet Gynecol; 1998 Jun; 41(2):405-21. PubMed ID: 9646973
    [No Abstract]   [Full Text] [Related]  

  • 34. Evidence-based tools for premenstrual disorders.
    Danis P; Drew A; Lingow S; Kurz S
    J Fam Pract; 2020; 69(1):E9-E17. PubMed ID: 32017837
    [No Abstract]   [Full Text] [Related]  

  • 35. [Premenstrual syndrome and serotonin reuptake inhibitors].
    Martin-Du-Pan RC
    Rev Med Suisse; 2010 Aug; 6(258):1517. PubMed ID: 20822060
    [No Abstract]   [Full Text] [Related]  

  • 36. Selections from current literature. Treatments for premenstrual dysphoric disorder.
    Carr M
    Fam Pract; 2001 Dec; 18(6):644-6. PubMed ID: 11739355
    [No Abstract]   [Full Text] [Related]  

  • 37. Treatment of premenstrual dysphoric disorder.
    Rapkin AJ; Lewis EI
    Womens Health (Lond); 2013 Nov; 9(6):537-56. PubMed ID: 24161307
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alprazolam, citalopram, and clomipramine for stuttering.
    Brady JP; Ali Z
    J Clin Psychopharmacol; 2000 Apr; 20(2):287. PubMed ID: 10770483
    [No Abstract]   [Full Text] [Related]  

  • 39. Luteal phase administration of agents for the treatment of premenstrual dysphoric disorder.
    Freeman EW
    CNS Drugs; 2004; 18(7):453-68. PubMed ID: 15139800
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expert guidelines for the treatment of severe PMS, PMDD, and comorbidities: the role of SSRIs.
    Steiner M; Pearlstein T; Cohen LS; Endicott J; Kornstein SG; Roberts C; Roberts DL; Yonkers K
    J Womens Health (Larchmt); 2006; 15(1):57-69. PubMed ID: 16417420
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.